GSK3B and diabetes mellitus: By inhibiting GSK-3β and affecting oxidative stress, apoptosis, calcium overload, and mPTP opening, DEX preconditioning presumably shields the myocardium from diabetes-induced activation of GSK-3β-mediated pathogenic effects (Chang et al., 2020; Guo et al., 2020).